Pfizer recalls

3 recalls.

• Levoxyl recall (Pfizer)
  DrugClass IIReported October 28, 2026 · Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
• Levoxyl recall (Pfizer)
  DrugClass IIReported October 28, 2026 · Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
• Dopamine HCl Inj. recall (Pfizer)
  DrugClass IIReported September 23, 2026 · Lack of Assurance of Sterility